Concepedia

Clark A. Sehon

CA

Statistics

Publications

22

Citations

4.1K

H-Index

18

Active since

1995

Affiliations

GlaxoSmithKline (United States)(Current)

Johnson & Johnson (United States)

The University of Texas at Austin

Emory University

GlaxoSmithKline (United Kingdom)

Clark A. Sehon is an author at GlaxoSmithKline (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1995–2019

22

Publications

22

Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL

William J. Kaiser, Haripriya Sridharan, Chunzi Huang et al. · Journal of Biological Chemistry · 2013 · 941 citations · Full text

, , +17

MLKL Compromises Plasma Membrane Integrity by Binding to Phosphatidylinositol Phosphates

Yves Dondelinger, Wim Declercq, Sylvie Montessuit et al. · Cell Reports · 2014 · 818 citations · Full text

, , +14

RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity

Pratyusha Mandal, Scott B. Berger, Sirika Pillay et al. · Molecular Cell · 2014 · 615 citations · Full text

, , +12

Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases

Philip A. Harris, Scott B. Berger, Jae Uk Jeong et al. · Journal of Medicinal Chemistry · 2017 · 475 citations · Full text

, , +15

Total Syntheses of Ningalin A, Lamellarin O, Lukianol A, and Permethyl Storniamide A Utilizing Heterocyclic Azadiene Diels−Alder Reactions

Dale L. Boger, Christopher W. Boyce, Marc Labroli et al. · Journal of the American Chemical Society · 1998 · 384 citations

, , +17

1–5 of 22